Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human CNTN5 ELISA Kit (AC2990)
Cat.#: ASET-1579
Specifications
Description Human CNTN5 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CNTN5 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.32 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1975 Human SOX6 ELISA Kit (AC3386) Quantitative inquiry ASET-1241 Rat Wnt5a ELISA Kit (AC2652) Quantitative inquiry ASET-1682 Human Somatostatin ELISA Kit (AC3093) Quantitative inquiry ASET-1387 Human beta 1 Adrenergic Receptor ELISA Kit (AC2798) Quantitative inquiry ASET-2334 Mouse ACTH ELISA Kit (AC3745) Quantitative inquiry ASET-1905 Human Myelin Basic Protein ELISA Kit (AC3316) Quantitative inquiry ASET-2324 Mouse SEMA3D ELISA Kit (AC3735) Quantitative inquiry ASET-2146 Human PTF1A ELISA Kit (AC3557) Quantitative inquiry ASET-1786 Human NK-1R ELISA Kit (AC3197) Quantitative inquiry ASET-1331 Rat Glutamate Receptor 1 (AMPA subtype) ELISA Kit (AC2742) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket